NSE · GLAND
Gland Pharma Limited
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#207
of 5,072 stocks
▲ 41W
Peak #207 · 27 Sep 2026
Gland Pharma Limited is a largecap company in the Healthcare space and carries a steep earnings multiple that prices in strong future growth, is well-owned by domestic institutions (30% DII), and is growing revenue at a solid clip.
Market Cap
48,122.13 Cr
P/E Ratio
46.45
P/B Ratio
4.61
ROE
9.92%
ROCE
13.96%
Dividend Yield
—
52W High
—
52W Low
—
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 | Q2 2025-26 |
|---|---|---|---|---|
| Revenue | 1,800.27 Cr | 1,742.79 Cr | 1,695.36 Cr | 1,486.88 Cr |
| Net Profit | 316.96 Cr | 366.68 Cr | 261.48 Cr | 183.68 Cr |
| EPS | 19.23 | 22.26 | 15.87 | 11.15 |
| Operating Profit | 439.34 Cr | 515.83 Cr | 390.40 Cr | 291.74 Cr |
Shareholding pattern
Promoter
51.77%
Public
48.23%
PUBLIC BREAKDOWN
FII
8.74%
DII
30.44%
MF (within DII)
28.23%
Individuals
3.74%
Mutual fund holdings
₹12,047.76
Cr total
136
Schemes
27
Fund Houses
₹12,047.76 Cr
Total Exposure
HDFC Mutual Fund₹2,762.44 Cr (22.9%)
Nippon India Mutual Fund₹2,364.69 Cr (19.6%)
Mirae Asset Mutual Fund₹1,715.39 Cr (14.2%)
SBI Mutual Fund₹1,522.42 Cr (12.6%)
DSP Mutual Fund₹674.03 Cr (5.6%)
Others₹3,008.78 Cr (25.0%)
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 11 Aug 2026 | Dividend | Dividend - Rs 20 Per Sh |
| 14 Aug 2025 | Dividend | Dividend - Rs 18 Per Share |
| 16 Aug 2024 | Dividend | Annual General Meeting/Dividend - Rs 20 Per Share |
| 06 Aug 2021 | Other | Annual General Meeting |
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.